GlassScriptPhysician profile
Travis Marshall Johnson
NPI 1346603859
$2,145.14
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $246 · 2021: $107 · 2022: $131 · 2023: $87.33 · 2024: $28.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,331.24 | 2019-2022 | |
| Mid-Atlantic Surgical Systems, LLC | $480.52 | 2019 | |
| Acell, INC. | $108.63 | 2019 | |
| Integra Lifesciences Corporation | $59.84 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ibsa Pharma INC. | $35.84 | 2023 | Tirosint, Licart |
| Kci USA, INC. | $28.84 | 2023 | Activ.A.C. |
| Zimmer Biomet Holdings, INC. | $28.70 | 2024 | Tapestry |
| Stryker Corporation | $18.51 | 2021 | |
| Embody, INC. | $14.88 | 2021 | |
| Orthofix Medical, INC. | $14.28 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.41 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.